Natural products to drugs: daptomycin and related lipopeptide antibiotics
Top Cited Papers
- 4 November 2005
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 22 (6) , 717-741
- https://doi.org/10.1039/b416648p
Abstract
Covering: 1953 to September 2005 Daptomycin (Cubicin®) is a lipopeptide antibiotic approved in the USA in 2003 for the treatment of skin and skin structure infections caused by Gram-positive pathogens. It is a member of the 10-membered cyclic lipopeptide family of antibiotics that includes A54145, calcium-dependent antibiotic (CDA), amphomycin, friulimicin, laspartomycin, and others. This review highlights research on this class of antibiotics from 1953 to 2005, focusing on more recent studies with particular emphasis on the interplay between structural features and antibacterial activities; chemical modifications to improve activity; the genetic organization and biosynthesis of lipopeptides; and the genetic engineering of the daptomycin biosynthetic pathway to produce novel derivatives for further chemical modification to develop candidates for clinical evaluation.Keywords
This publication has 197 references indexed in Scilit:
- Necrotizing Fasciitis Caused by Community-Associated Methicillin-ResistantStaphylococcus aureusin Los AngelesNew England Journal of Medicine, 2005
- Antimicrobial activity of daptomycin against multidrug-resistant gram-positive strains collected worldwideDiagnostic Microbiology and Infectious Disease, 2004
- The mcyF gene of the microcystin biosynthetic gene cluster from Microcystis aeruginosa encodes an aspartate racemaseBiochemical Journal, 2003
- Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)Nature, 2002
- The lipopeptide antibiotic A21978C has a specific interaction with DMPC only in the presence of calcium ionsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- A comparative monomolecular film study of antibiotic A21978C homologues of various lipid chain lengthBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Conformational change on calcium binding by the lipopeptide antibiotic amphomycin. A C.D. and monolayer studyBiochemical and Biophysical Research Communications, 1988
- The role of acyl chain character and other determinants on the bilayer activity of A21978C an acidic lipopeptide antibioticBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986
- Proline hydroxylation by cell free extract of a streptomyceteBiochemical and Biophysical Research Communications, 1984
- Amphomycin inhibits phospho-N-acetylmuramyl-pentapeptide translocase in peptidoglycan synthesis of BacillusBiochemical and Biophysical Research Communications, 1979